These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7229450)

  • 1. [A clinicopathological study on microinvasive carcinoma (stage Ia) of the uterine cervix (author's transl)].
    Yoshida S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):127-35. PubMed ID: 7229450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small FIGO stage IB cervical cancer.
    Girardi F; Burghardt E; Pickel H
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):427-32. PubMed ID: 7835783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microinvasive stage Ia cancer of the uterine cervix--results of a multicenter clinic based analysis].
    Ebeling K; Bilek K; Johannsmeyer D; Rohde E; Wagner F; Buchmann J; Heiner M; Johannsmeyer B; Glodde L; Rüdiger KD
    Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):776-81. PubMed ID: 2806850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significance of invasion and vessel permeation in squamous cell carcinoma of the uterine cervix with invasion to a depth of 3 mm or less].
    Otsuka I; Ozaki Y; Nagano H; Mizutani K; Murakami A; Ueda K; Funata N
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Nov; 47(11):1261-7. PubMed ID: 8543852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative surgical treatment in cervical cancer with 3 to 5 mm stromal invasion in the absence of confluent invasion and lymph-vascular space involvement.
    Yaegashi N; Sato S; Inoue Y; Noda K; Yajima A
    Gynecol Oncol; 1994 Sep; 54(3):333-7. PubMed ID: 8088610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early invasive adenocarcinoma of the uterine cervix: criteria for nonradical surgical treatment.
    Kasamatsu T; Okada S; Tsuda H; Shiromizu K; Yamada T; Tsunematsu R; Ohmi K
    Gynecol Oncol; 2002 May; 85(2):327-32. PubMed ID: 11972396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The study of ovarian metastasis in uterine cancer].
    Aida H; Kodama S; Aoki Y; Shimizu K; Honma S; Kanazawa K; Tanaka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):315-22. PubMed ID: 1607754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix.
    Gauthier P; Gore I; Shingleton HM; Soong SJ; Orr JW; Hatch KD
    Obstet Gynecol; 1985 Oct; 66(4):569-74. PubMed ID: 4047545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma.
    Atasii T; Aksu MF; Cetinkaya MB
    Int Surg; 2000; 85(2):147-51. PubMed ID: 11071333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histopathological study of carcinoma of the cervix stage Ia].
    Jobo T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):349-58. PubMed ID: 2984297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
    Bosković V; Glisić A; Petković S
    Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer.
    Okada M; Kigawa J; Minagawa Y; Kanamori Y; Shimada M; Takahashi M; Oishi T; Terakawa N
    Gynecol Oncol; 1998 Jul; 70(1):61-4. PubMed ID: 9698475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early invasive carcinoma of the cervix.
    Jones WB; Mercer GO; Lewis JL; Rubin SC; Hoskins WJ
    Gynecol Oncol; 1993 Oct; 51(1):26-32. PubMed ID: 8244170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
    Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
    Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Status of surgery in therapy of cervix cancer].
    Hetzel H; Müller E; Dapunt O
    Wien Klin Wochenschr; 1987 May; 99(10):1-16. PubMed ID: 3604210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of magnetic resonance imaging (MRI) in evaluation of the extension of uterine cervical cancer].
    Matsubara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1115-22. PubMed ID: 8245590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.